A retrospective study of oral prednisolone treatment in canine chronic hepatitis

References

• Bolkenius U, Hahn D, Gressner AM, Breitkopf K, Dooley S, Wickert L. 2004. Glucocorticoids decrease the bioavailability of TGF-beta which leads to a reduced TGF-beta signaling in hepatic stellate cells. Biochem Biophys Res Commun. 325:1264–1270.
   PubMed Web of Science ®Google Scholar
• Boomkens SY, Slump E, Egberink HF, Rothuizen J, Penning LC. 2005. PCR screening for candidate etiological agents of canine hepatitis. Vet Microbiol. 108:49–55.
   PubMed Web of Science ®Google Scholar
• Brewer GJ, Dick RD, Schall W, Yuzbasiyan-Gurkan V, Mullaney TP, Pace C, Lindgren J, Thomas M, Padgett G. 1992. Use of zinc acetate to treat copper toxicosis in dogs. J Am Vet Med Assoc. 201:564–568.
   PubMed Web of Science ®Google Scholar
• Brotman DJ, Girod JP, Posch A, Jani JT, Patel JV, Gupta M, Lip GYH, Reddy S, Kickler TS. 2006. Effects of short-term glucocorticoids on hemostatic factors in healthy volunteers. Tromb Res. 118:247–252.
   PubMed Web of Science ®Google Scholar
• Cole TL, Center SA, Flood SN, Rowland PH, Valentine BA, Warner KL, Erb HN. 2002. Diagnostic comparison of needle and wegde biopsy specimens of the liver in dogs and cats. J Am Vet Med Assoc. 220:1483–1490.
   PubMed Web of Science ®Google Scholar
• Cullen JM, van den Ingh TSGAM, Van Winkle T, Charles JA, Desmet VJ. 2006. WSAVA liver standardization group: standards for clinical and histological diagnosis of canine and feline liver diseases. Philidelphia (PA): Saunders Elsevier. Chapter 6, Morphological classification of parenchymal disorders of the canine and feline liver: 1 Normal histology, reversible hepatocytic injury and hepatic amyloidosis; p. 77–84.
   Google Scholar
• Dal Bo Zanon R, Fornasiero L, Boscaro M, Cappellato G, Fabris F, Girolami A. 1982. Increased factor VIII associated activities in Cushing's syndrome: a probable hypercoagulable state. Thromb Haemost. 47:116–117.
   PubMed Web of Science ®Google Scholar
• Decaro N, Campolo M, Elia G, Buonavoglia D, Colaianni ML, Lorusso A, Mari V, Buonavoglia C.2005. Infectious canine hepatitis: an “old” disease reemerging in Italy. Res Vet Sci. 83:269–273.
   Web of Science ®Google Scholar
• Favier RP. 2009. Veterinary clinics of North America – small animal practice: hepatology. Philidelphia (PA): Saunders Elsevier. Idiopathic hepatitis and cirrhosis in dogs; p. 481–488.
   Google Scholar
• Henderson NC, Iredale JP. 2007. Liver fibrosis: cellular mechanisms of progression and resolution. Clin Sci (Lond). 112:265–280.
   PubMed Web of Science ®Google Scholar
• Hoffmann G, van den Ingh TSGAM, Bode P, Rothuizen J. 2006. Copper-associated chronic hepatitis in Labrador Retrievers. J Vet Intern Med. 20:856–861.
   PubMed Web of Science ®Google Scholar
• Honeckman A. 2003. Current concepts in the treatment of canine chronic hepatitis. Clin Tech Small Anim Pract. 18:239–244.
   PubMedGoogle Scholar
• Iredale JP. 2007. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest. 117:539–548.
   PubMed Web of Science ®Google Scholar
• Ishak KG. 2000. Pathologic features of chronic hepatitis: a review and update. Am J Clin Pathol. 113:40–55.
   PubMed Web of Science ®Google Scholar
• Jacoby RC, Owings JT, Ortega T, Gosselin R, Feldman EC. 2001. Biochemical basis for the hypercoagulable state seen in Cushing syndrome; discussion 1006-7. Arch Surg. 136:1003–1006.
   PubMed Web of Science ®Google Scholar
• Mandigers PJ, van den Ingh TS, Bode P, Teske E, Rothuizen J. 2005. Improvement in liver pathology after 4 months of D-penicillamine in 5 doberman pinschers with subclinical hepatitis. J Vet Intern Med. 19:40–43.
   PubMed Web of Science ®Google Scholar
• Newman SJ, Smith JR, Stenske KA, Newman LB, Dunlap JR, Imerman PM, Kirk CA. 2007. Aflatoxicosis in nine dogs after exposure to contaminated commercial dog food. J Vet Diagn Invest. 19:168–175.
   PubMed Web of Science ®Google Scholar
• Poldervaart JH, Favier RP, Penning LC, van den Ingh TSGAM, Rothuizen J. 2009. Primary hepatitis in dogs: a retrospective review (2002–2006). J Vet Intern Med. 23:72–80.
   PubMed Web of Science ®Google Scholar
• Prins M, Schellens CJMM, van Leeuwen MW, Rothuizen J, Teske E. 2010. Coagulation disorders in dogs with hepatic disease. Vet J. 185:163–168.
   PubMed Web of Science ®Google Scholar
• Raffan E, McCallum A, Scase TJ, Watson PJ. 2009. Ascites is a negative prognostic indicator in chronic hepatitis in dogs. J Vet Intern Med. 23:63–66.
   PubMed Web of Science ®Google Scholar
• Rallis T, Day MJ, Saridomichelakis MN, Adamama-Moraitou KK, Papazoglou L, Fytianou A, Koutinas AF. 2005. Chronic hepatitis associated with canine leishmaniosis (Leishmania infantum): a clinicopathological study of 26 cases. J Comp Pathol. 132:145–152.
   PubMed Web of Science ®Google Scholar
• Rothuizen J, Desmet VJ, van den Ingh TSGAM, Twedt DC, Bunch SE, Washabau RJ. 2006. WSAVA liver standardization group. Standards for clinical and histological diagnosis of canine and feline liver diseases. Philidelphia (PA): Saunders Elsevier. Chapter 2, Sampling and handling of liver tissue; p. 5–14.
   Google Scholar
• Schlichting P, Holund B, Poulsen H. 1983. Liver biopsy in chronic aggressive hepatitis: diagnostic reproducibility in relation to size of specimen. Scand J Gastroenterol. 18:27–32.
   PubMed Web of Science ®Google Scholar
• Small M, Lowe GD, Forbes CD, Thomson JA. 1983. Thromboembolic complications in Cushing's syndrome. Clin Endocrinol (Oxf). 19:503–511.
   PubMed Web of Science ®Google Scholar
• Smedley R, Mullaney T, Rumbeiha W. 2009. Copper-associated hepatitis in Labrador retrievers. Vet Pathol. 46:484–490.
   PubMed Web of Science ®Google Scholar
• Spee B, Arends B, van den Ingh TS, Penning LC, Rothuizen J. 2006. Copper metabolism and oxidative stress in chronic inflammatory and cholestatic liver diseases in dogs. J Vet Intern Med. 20:1085–1092.
   PubMed Web of Science ®Google Scholar
• Strombeck DR, Miller LM, Harrold D. 1998. Effects of corticosteroid treatment on survival time in dogs with chronic hepatitis: 151 cases (1977–1985). J Am Vet Med Assoc. 193:1109–1113.
   Google Scholar
• Van den Ingh TSGAM, Rothuizen J, Cupery R. 1988. Chronic active hepatitis with cirrhosis in the Doberman pinscher. Vet Quart. 10:84–89.
   PubMed Web of Science ®Google Scholar
• Van den Ingh TSGAM, Van Winkle TJ, Cullen JM, Charles JA, Desmet VJ. 2006. WSAVA liver standardization group. Standards for clinical and histological diagnosis of canine and feline liver diseases. Philidelphia (PA): Saunders Elsevier. Chapter 7, Morphological classification of parenchymal disorders of the canine and feline liver; p. 85–101.
   Google Scholar
• Wagner KA, Hartmann FA, Trepanier LA. 2007. Bacterial culture results from liver, gallbladder, or bile in 248 dogs and cats evaluated for hepatobiliary disease: 1998–2003. J Vet Intern Med. 21:417–424.
   PubMed Web of Science ®Google Scholar
• Watson PJ. 2004. Chronic hepatitis in dogs: a review of current understanding of the aetiology, progression, and treatment. Vet J. 167:228–241.
   PubMed Web of Science ®Google Scholar
• Wickert L, Abiaka M, Bolkenius U, Gressner AM. 2004. Corticosteroids stimulate selectively transforming growth factor (TGF)-beta receptor type III expression in transdifferentiating hepatic stellate cells.J Hepatol. 40:69–76.
   PubMed Web of Science ®Google Scholar